Structural variation (SV), BioNano’s area of specialization, is more than a next generation of gene sequencing; it’s taking the field in a different direction altogether.

SAN DIEGO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by the Human Genome Stru ...

By using Genoox technology for aligning short read sequence data to Bionano’s SV calls, the high sensitivity of Bionano calls will be combined with the basepair precision of NGS. The ...

SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ...

Wild stock market moves are a familiar sight in 2020 for investors of BioNano Genomics (BNGO). The cytogenetics specialist’s shares are prone to swing strongly in either direction, although ...

Bionano is likely to become a clinical lab instead of a Life Science equipment ... NGS companies have only started to pay serious attention to SV and whole-genome sequencing only recently, ...

Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the ...

A high-level overview of Bionano Genomics, Inc. (BNGO) stock. View (BNGO) real-time stock price, chart, news, analysis, analyst reviews and more.